Taken together, these data provide further evidence concerning a key role for PAD4 in the underlying etiology of RA, and offer a potential explanation for the efficacy of PAD4 inhibitor chloramidine in reducing disease symptoms in collagen-induced rat and murine arthritis models for RA[36]. Here, PADI4 is linked to arthritic joint disease.